Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Guy

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|March 18, 2021
Anomalous Motion of Charged Domain Walls and Associated Negative Capacitance in Copper-Chlorine BoraciteJoseph G M Guy, Charlotte Cochard, Pablo Aguado-Puente, et al.
British Journal of Cancer|May 29, 2008
Diagnostic radiation procedures and risk of prostate cancerP Myles, S Evans, A Lophatananon, et al.
British Journal of Cancer|April 21, 2012
Germline BRCA1 mutations increase prostate cancer riskD Leongamornlert, N Mahmud, M Tymrakiewicz, et al.
Oncogene|September 29, 2021
Regulation of a progenitor gene program by SOX4 is essential for mammary tumor proliferationM Guy Roukens, Cynthia L Frederiks, Danielle Seinstra, et al.
British Journal of Cancer|September 29, 2011
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patientsZ Kote-Jarai, D Leongamornlert, E Saunders, et al.
British Journal of Cancer|June 28, 2002
High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to boneJ M O'Sullivan, V R McCready, G Flux, et al.
British Journal of Cancer|December 10, 2009
Mutation analysis of the MSMB gene in familial prostate cancerZ Kote-Jarai, D Leongamornlert, M Tymrakiewicz, et al.
British Journal of Cancer|February 22, 2014
Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced diseaseD Leongamornlert, E Saunders, T Dadaev, et al.
The Lancet. Microbe|December 3, 2022
Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trialAdam P Dale, Anastasia A Theodosiou, Diane F Gbesemete, et al.
British Journal of Cancer|January 8, 2009
A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancerZ Kote-Jarai, S Jugurnauth, S Mulholland, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Advanced Materials (Deerfield Beach, Fla.)|March 18, 2021
Anomalous Motion of Charged Domain Walls and Associated Negative Capacitance in Copper-Chlorine BoraciteJoseph G M Guy, Charlotte Cochard, Pablo Aguado-Puente, et al.
British Journal of Cancer|May 29, 2008
Diagnostic radiation procedures and risk of prostate cancerP Myles, S Evans, A Lophatananon, et al.
British Journal of Cancer|April 21, 2012
Germline BRCA1 mutations increase prostate cancer riskD Leongamornlert, N Mahmud, M Tymrakiewicz, et al.
Oncogene|September 29, 2021
Regulation of a progenitor gene program by SOX4 is essential for mammary tumor proliferationM Guy Roukens, Cynthia L Frederiks, Danielle Seinstra, et al.
British Journal of Cancer|September 29, 2011
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patientsZ Kote-Jarai, D Leongamornlert, E Saunders, et al.
British Journal of Cancer|June 28, 2002
High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to boneJ M O'Sullivan, V R McCready, G Flux, et al.
British Journal of Cancer|December 10, 2009
Mutation analysis of the MSMB gene in familial prostate cancerZ Kote-Jarai, D Leongamornlert, M Tymrakiewicz, et al.
British Journal of Cancer|February 22, 2014
Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced diseaseD Leongamornlert, E Saunders, T Dadaev, et al.
The Lancet. Microbe|December 3, 2022
Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trialAdam P Dale, Anastasia A Theodosiou, Diane F Gbesemete, et al.
British Journal of Cancer|January 8, 2009
A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancerZ Kote-Jarai, S Jugurnauth, S Mulholland, et al.
Pageof 20